Sirturo FDA Approval History
FDA Approved: Yes (First approved December 28, 2012)
Brand name: Sirturo
Generic name: bedaquiline
Dosage form: Tablets
Company: Janssen Research & Development, LLC
Treatment for: Tuberculosis, Resistant
Sirturo (bedaquiline) is an oral diarylquinoline antimycobacterial drug indicated for the treatment of pulmonary multi-drug resistant tuberculosis.
Development Timeline for Sirturo
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.